Clinical trial
Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
NCT00643656 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
- Lead sponsor
- Air Liquide Santé International
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 94 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver biopsy